Navigation Links
Research!America Honors Univ. of Chicago Economists for Study Showing Economic Impact of HIV/AIDS Drug Development
Date:10/9/2007

ad."

Citing the importance of the Garfield Award in encouraging further study in this area, Mary Woolley, Research!America's president, said, "We need much more work like that of Dr. Philipson and Dr. Jena to show how important health-related research is for our nation's economy as well as our length and quality of life."

About the 2007 Recipients

Tomas Philipson, Ph.D., is a tenured professor in the Irving B. Harris Graduate School of Public Policy Studies at the University of Chicago. He is also a faculty member of the university's Department of Economics and its Law School. One of the nation's leading experts in the field of health economics, he has served as a senior economic adviser to the U.S. government.

Anupam Jena completed his Ph.D. in economics at the University of Chicago in 2006 as part of the University's Medical Scientist (MD/Ph.D.) Training Program. He is currently a third-year medical student at the University of Chicago and a Bing Center Visiting Fellow at the Rand Corporation. His research has focused on the economic value of medical innovation, implications of cost-effectiveness policies for technological growth and the economics of fertility.

About Research!America

Research!America is the nation's largest not-for-profit public education and advocacy alliance working to make research to improve health a higher national priority. Founded in 1989, Research!America is supported by more than 500 member organizations that represent the voices of more than 125 million Americans.

Ms. Woolley is available for further comment.


'/>"/>
SOURCE Research!America
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. US Academy honors 15 for major contributions to science
2. American Cancer Society Honors Exemplary Cancer Caregivers
3. Johns Hopkins Medicine Honors U.A.E. Sheikh Zayed Bin Sultan Al Nahyan
4. Baltimore is Americas Fittest City; Chicago the Fattest
5. Chicago :FDA imposes Ban on Biomedical Tissue Services
6. Chicago: Dad, I need you desperately, Please come back
7. Couples To Swap Kidneys In Chicago
8. Funds Allocated to Illinois and Chicago to Prepare in Case of a Flu Pandemic
9. Food Poisoning at the Chicago Food Festival
10. Rural Canadians travel far for specialists: study
11. A new study surpasses Gene Therapy Hurdle
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3Disrupting a destructive duo 3A U of T Mississauga researchers inhibit cancer proteins 9634 1Disrupting a destructive duo 3A U of T Mississauga researchers inhibit cancer proteins 9634 2Ochsner and Rouses Markets Partner for Choose Healthy Initiative 54965 1Ochsner and Rouses Markets Partner for Choose Healthy Initiative 54965 2Ochsner and Rouses Markets Partner for Choose Healthy Initiative 54965 3Nostrils Compete to Relay Key Fragrance 54963 1Nostrils Compete to Relay Key Fragrance 54963 2